Arcutis Biotherapeutics ARQT

$ 8.86 1.61%

Quarterly report 2024-Q2
added 08-14-2024

Arcutis Biotherapeutics Income Statement 2011-2024 | ARQT

Annual Income Statement Arcutis Biotherapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	747 M	882 M	1.02 B	1 B	-	-	-	-	-	-	-	-	-
Shares	69.3 M	55 M	49.4 M	35.7 M	-	-	-	-	-	-	-	-	-
Historical Prices	10.8	16	20.7	28.1	-	-	-	-	-	-	-	-	-
Net Income	-262 M	-311 M	-206 M	-136 M	-42 M	-19.3 M	-4.98 M	-	-	-	-	-	-
Revenue	59.6 M	3.69 M	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	4.99 M	754 K	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-241 M	-302 M	-207 M	-137 M	-43.1 M	-19.7 M	-	-	-	-	-	-	-
Interest Expense	29.7 M	15.7 M	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-240 M	-301 M	-206 M	-137 M	-42.9 M	-19.7 M	-4.11 M	-	-	-	-	-	-
Operating Expenses	-	-	-	137 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	185 M	122 M	61 M	21.3 M	6.61 M	1.8 M	695 K	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Arcutis Biotherapeutics

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	123 M	111 M	96.8 M	61.7 M	61.4 M	61.2 M	61 M	57.1 M	51.4 M	50.5 M	50.3 M	50.1 M	50 M	47.3 M	43.3 M	37.7 M	37.6 M	24.3 M	2.12 M	1.92 M	1.77 M	1.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-52.3 M	-35.4 M	-	-44.8 M	-71 M	-80.1 M	-	-108 M	-67.4 M	-64.3 M	-	-57 M	-42 M	-36 M	-34 M	-38.2 M	-35.4 M	-28 M	-12.6 M	-14.5 M	-8.29 M	-6.66 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	30.9 M	49.6 M	-	38.1 M	5.19 M	2.78 M	-	725 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	3.46 M	3.26 M	-	-	776 K	783 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-50.1 M	-31.6 M	-	-36.9 M	-66.8 M	-76.3 M	-	-105 M	-65.8 M	-62.6 M	-	-57.1 M	-42.1 M	-36.1 M	-	-38.3 M	-35.6 M	-28.7 M	-	-14.6 M	-8.54 M	-6.95 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	5.23 M	7.48 M	-	7.56 M	3.12 M	7.04 M	-	4.9 M	2 M	1.84 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-49.9 M	-31.5 M	-	-36.7 M	-66.6 M	-76.1 M	-	-105 M	-65.7 M	-62.5 M	-	-57 M	-42 M	-36 M	-	-38.3 M	-35.6 M	-28.6 M	-	-14.6 M	-8.51 M	-6.95 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	75 M	72 M	79 M	-	105 M	65.8 M	62.6 M	-	57.1 M	42.1 M	36.1 M	34.1 M	38.3 M	35.6 M	28.7 M	13 M	14.6 M	8.54 M	6.95 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	58.2 M	54.8 M	-	47.6 M	46 M	42.9 M	-	35.5 M	27.6 M	22 M	-	16.5 M	11.3 M	14.5 M	-	5.56 M	5.62 M	3.47 M	-	2.3 M	1.32 M	749 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency